CD8A and hepatocellular carcinoma: As disease progresses from steatosis to fibrosis and ultimately to HCC, CD8+ T-cell bioenergetics decline substantially, with a reduction in oxidative phosphorylation (OXPHOS) and in glycolytic flux (58).